Retatrutide, from Soma Pharmaceuticals , is attracting increasing attention as a novel method for obesity control . This innovative compound merges the activity of a GLP-1 receptor activator and a GIP receptor stimulant, designed to not only promote reduced body soma chems retatrutide fat but also address underlying metabolic conditions . Early cli